おすすめの製品
品質水準
形状
(transparent gel)
粘度
0.1-1 Pa.s (high shear)
200-2500 Pa.s low (shear)
ゲル強度
(Storage modulus after UV crosslinking (kPa) 2-6)
詳細
The shear-thinning gelatin-based bioink is a extracellular matrix (ECM)- mimicking ink that provides all the benefits of gelatin with the addition of shear thinning behaviour, thereby allowing easy printing at 37°C.
Based on gelatin derived from natural collagen, this bioink has been modified with photocrosslinkable functional groups which enables unpreedneted printing efficiency of a scaffold that resembes the natural ECM and has exptionally high cell viabilities. The shear-thinning gelatin-based bioink combines all the benefits of conventional gelatin or GelMA with the improved printability thanks to its shear thinning behavior. It can be printed at 37°C in the presence or absence of cells, and overcomes the narrow processing range limitations associated with printing conventional GelMA based bioinks. After printing, the material can be photocrosslinked, resunting in a physiologically stable hydrogel.
Processing:
At high shear rates, this bioink exhibits a low viscotiy which allows easy injection from the printing nozzle, At low shear rates, it has a high viscosity, which is required for shape retention after deposition. This is favorable for extrusion-based 3D bioprinters as the ink should easily be injected through the printing nozzle and the post-injetion flow should be minimized to prevent structural deformation. These properties are very rarely seen in conventional gelatin-based ink, giving this bioink an advantage over traditional bioinks.
Based on gelatin derived from natural collagen, this bioink has been modified with photocrosslinkable functional groups which enables unpreedneted printing efficiency of a scaffold that resembes the natural ECM and has exptionally high cell viabilities. The shear-thinning gelatin-based bioink combines all the benefits of conventional gelatin or GelMA with the improved printability thanks to its shear thinning behavior. It can be printed at 37°C in the presence or absence of cells, and overcomes the narrow processing range limitations associated with printing conventional GelMA based bioinks. After printing, the material can be photocrosslinked, resunting in a physiologically stable hydrogel.
Processing:
At high shear rates, this bioink exhibits a low viscotiy which allows easy injection from the printing nozzle, At low shear rates, it has a high viscosity, which is required for shape retention after deposition. This is favorable for extrusion-based 3D bioprinters as the ink should easily be injected through the printing nozzle and the post-injetion flow should be minimized to prevent structural deformation. These properties are very rarely seen in conventional gelatin-based ink, giving this bioink an advantage over traditional bioinks.
アプリケーション
Applications: :
3D bioprinting
Tissue engineering
In vitro modeling
3D bioprinting
Tissue engineering
In vitro modeling
特徴および利点
Features and Benefits:
- Easy printing - Shear thinning behavior enables easy deposition at 37°C
- Biodegradability - Enables cellular remodeling of the printed matrix
- Easy handling - Delivered in a ready-to-use cartridge - UV curable
- Efficient UV-based crosslinking
- Reproducibility - Strict quality control
Cell interactive - Material is biocompatible mimics natural ECM envrionment
- Easy printing - Shear thinning behavior enables easy deposition at 37°C
- Biodegradability - Enables cellular remodeling of the printed matrix
- Easy handling - Delivered in a ready-to-use cartridge - UV curable
- Efficient UV-based crosslinking
- Reproducibility - Strict quality control
Cell interactive - Material is biocompatible mimics natural ECM envrionment
保管分類コード
10 - Combustible liquids
WGK
WGK 3
引火点(°F)
Not applicable
引火点(℃)
Not applicable
適用法令
試験研究用途を考慮した関連法令を主に挙げております。化学物質以外については、一部の情報のみ提供しています。 製品を安全かつ合法的に使用することは、使用者の義務です。最新情報により修正される場合があります。WEBの反映には時間を要することがあるため、適宜SDSをご参照ください。
Jan Code
935786-1EA-PW:
935786-1EA:
試験成績書（COA）
製品のロット番号・バッチ番号を入力して、試験成績書（COA） を検索できます。ロット番号・バッチ番号は、製品ラベルに「Lot」または「Batch」に続いて記載されています。
Olivier Guillaume et al.
Acta biomaterialia, 165, 72-85 (2022-03-16)
Since its inception, tissue engineering and regenerative medicine (TERM) has been relying on either scaffold-based or scaffold-free strategies. Recent reports outlined the possibility of a synergistic, convergence approach, referred to as the third TERM strategy, which could alleviate bottlenecks of
ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.
製品に関するお問い合わせはこちら（テクニカルサービス）